Search Results - "Bell, Beth P."

The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide by Perz, Joseph F., Armstrong, Gregory L., Farrington, Leigh A., Hutin, Yvan J.F., Bell, Beth P.

“…End-stage liver disease accounts for one in forty deaths worldwide. Chronic infections with hepatitis B virus (HBV) and hepatitis C virus (HCV) are…”
Get full text

The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020 by Oliver, Sara E, Gargano, Julia W, Marin, Mona, Wallace, Megan, Curran, Kathryn G, Chamberland, Mary, McClung, Nancy, Campos-Outcalt, Doug, Morgan, Rebecca L, Mbaeyi, Sarah, Romero, José R, Talbot, H Keipp, Lee, Grace M, Bell, Beth P, Dooling, Kathleen

“…On December 11, 2020, the Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the Pfizer-BioNTech COVID-19 (BNT162b2) vaccine…”
Get full text

Antibody Levels and Protection after Hepatitis B Vaccine: Results of a 22-Year Follow-Up Study and Response to a Booster Dose by McMahon, Brian J., Dentinger, Catherine M., Bruden, Dana, Zanis, Carolyn, Peters, Helen, Hurlburt, Debbie, Bulkow, Lisa, Fiore, Anthony E., Bell, Beth P., Hennessy, Thomas W.

“…BackgroundThe duration of protection in children and adults (including health care workers) resulting from the hepatitis B vaccine primary series is unknown…”
Get full text

The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Moderna COVID-19 Vaccine - United States, December 2020 by Oliver, Sara E, Gargano, Julia W, Marin, Mona, Wallace, Megan, Curran, Kathryn G, Chamberland, Mary, McClung, Nancy, Campos-Outcalt, Doug, Morgan, Rebecca L, Mbaeyi, Sarah, Romero, José R, Talbot, H Keipp, Lee, Grace M, Bell, Beth P, Dooling, Kathleen

“…On December 18, 2020, the Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the Moderna COVID-19 (mRNA-1273) vaccine…”
Get full text

A mathematical model to estimate global hepatitis B disease burden and vaccination impact by Goldstein, Susan T, Zhou, Fangjun, Hadler, Stephen C, Bell, Beth P, Mast, Eric E, Margolis, Harold S

“…Background Limited data are available regarding global hepatitis B virus (HBV)-related morbidity and mortality and potential reduction in disease burden from…”
Get full text

Chronic liver disease mortality in the United States, 1990–1998 by Vong, Sirenda, Bell, Beth P.

“…In 1998, chronic liver disease (CLD) was the tenth leading cause of death in the U.S. Alcohol and hepatitis C are thought to be important etiologies. However,…”
Get full text

Overview, Control Strategies, and Lessons Learned in the CDC Response to the 2014-2016 Ebola Epidemic by Bell, Beth P, Damon, Inger K, Jernigan, Daniel B, Kenyon, Thomas A, Nichol, Stuart T, O'Connor, John P, Tappero, Jordan W

“…During 2014-2016, CDC, working with U.S. and international partners, mounted a concerted response to end the unprecedented epidemic of Ebola virus disease…”
Get more information

Declining Hepatitis A Mortality in the United States during the Era of Hepatitis A Vaccination by Vogt, Tara M., Wise, Matthew E., Bell, Beth P., Finelli, Lyn

“…BackgroundSince the mid-1990s, hepatitis A vaccine has been recommended for US children living in historically high-incidence states and for persons with other…”
Get full text

Challenges of infectious diseases in the USA by Khabbaz, Rima F, Dr, Moseley, Robin R, MAT, Steiner, Riley J, MPH, Levitt, Alexandra M, PhD, Bell, Beth P, MD

“…Summary In the USA, infectious diseases continue to exact a substantial toll on health and health-care resources. Endemic diseases such as chronic hepatitis,…”
Get full text

Ebola 2014 — New Challenges, New Global Response and Responsibility by Frieden, Thomas R, Damon, Inger, Bell, Beth P, Kenyon, Thomas, Nichol, Stuart

“…Stopping the Ebola outbreak at its source will take many months. But three core interventions have stopped every previous outbreak and can stop this one:…”
Get full text

Limitations of conventionally derived chronic liver disease mortality rates: Results of a comprehensive assessment by Manos, M. Michele, Leyden, Wendy A., Murphy, Rosemary C., Terrault, Norah A., Bell, Beth P.

“…Standard death certificate–based methods for ascertaining deaths due to chronic liver disease (CLD), such as the U.S. vital statistics approach, rely on a…”
Get full text

Hepatitis B Vaccination Coverage Levels Among Healthcare Workers in the United States, 2002‐2003 by Simard, Edgar P., Miller, Jeremy T., George, Prethibha A., Wasley, Annemarie, Alter, Miriam J., Bell, Beth P., Finelli, Lyn

“…Hepatitis B virus (HBV) infection is a well recognized risk for healthcare workers (HCWs), and routine vaccination of HCWs has been recommended since 1982. By…”
Get full text

Trends in Hepatitis C Virus Infection Among Patients in the HIV Outpatient Study, 1996–2007 by Spradling, Philip R, Richardson, James T, Buchacz, Kate, Moorman, Anne C, Finelli, Lyn, Bell, Beth P, Brooks, John T

“…BACKGROUND:Coinfection with hepatitis C virus (HCV) contributes increasingly to the morbidity and mortality of persons infected with HIV. We assessed HCV…”
Get full text

Persistence of Antibody to Hepatitis A Virus 10 Years after Vaccination among Children and Adults by Hammitt, Laura L., Bulkow, Lisa, Hennessy, Thomas W., Zanis, Carolyn, Snowball, Mary, Williams, James L., Bell, Beth P., McMahon, Brian J.

“…Background. Hepatitis A vaccination is effective in preventing disease. However, the duration of protection after vaccination is unknown. Methods. We enrolled…”
Get full text

Scientific and Ethical Principles Underlying Recommendations From the Advisory Committee on Immunization Practices for COVID-19 Vaccination Implementation by Bell, Beth P, Romero, José R, Lee, Grace M

“…This Viewpoint summarizes the principles guiding coronavirus disease 2019 (COVID-19) vaccine recommendations made by the Advisory Committee on Immunization…”
Get full text

Postapproval Vaccine Safety Surveillance for COVID-19 Vaccines in the US by Lee, Grace M, Romero, José R, Bell, Beth P

“…This Viewpoint reviews systems in place to monitor postlicensure vaccine safety, and recommends harmonizing end points and protocols across vaccine trials and…”
Get full text

National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003 by Ahmed, Faruque, Perz, Joseph F, Kwong, Sandy, Jamison, Patricia M, Friedman, Carol, Bell, Beth P

“…Previous studies indicate that the incidence of hepatocellular carcinoma in the United States is increasing. These reports, however, have contained limited…”
Get full text

Complementary and Alternative Medicine Use in Chronic Liver Disease Patients by Ferrucci, Leah M, Bell, Beth P, Dhotre, Kathy B, Manos, M Michele, Terrault, Norah A, Zaman, Atif, Murphy, Rosemary C, VanNess, Grace R, Thomas, Ann R, Bialek, Stephanie R, Desai, Mayur M, Sofair, Andre N

“…GOALSTo examine a wide range of sociodemographic and clinical characteristics as potential predictors of complementary and alternative medicine (CAM) use among…”
Get full text

Hepatitis E Virus Antibody Prevalence among Persons Who Work with Swine by Drobeniuc, Jan, Favorov, Michael O., Shapiro, Craig N., Bell, Beth P., Mast, Eric E., Dadu, Andrei, Culver, David, Iarovoi, Petru, Robertson, Betty H., Margolis, Harold S.

“…Prevalence of antibody and risk factors to hepatitis E virus (HEV) infection were determined in a cross-sectional study of 2 group-matched populations: swine…”
Get full text

Changing trends in hepatitis C–related mortality in the United States, 1995‐2004 by Wise, Matthew, Bialek, Stephanie, Finelli, Lyn, Bell, Beth P., Sorvillo, Frank

“…The disease burden and mortality from hepatitis C are predicted to increase in the United States as the number of persons with long‐standing chronic infection…”
Get full text